Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Dermatoses

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Dermatoses in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19904 (36.36)18.7374
1990's6 (54.55)18.2507
2000's0 (0.00)29.6817
2010's1 (9.09)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goto, S; Itoh, H; Nagai, M; Ohmori, K; Osada, H; Sasaki, K; Shimizu, S; Shimoda, M; Shirai, J; Watanabe, M1
Kagoshima, M; Komatsu, H; Okumoto, T; Tomomatsu, N; Yamaguchi, S1
Allen, A; Davies, D; Haskard, DO; Larbi, K; Lobb, RR; Nourshargh, S; Sanz, M; Weg, VB1
Iwahisa, Y; Okamoto, H; Terasawa, M1
Bernat, A; Herbert, JM; Laplace, MC; Maffrand, JP; Salel, V1
al Attiyah, R; Rook, GA; Rosen, H1
Colditz, IG1
Csatò, M; Czarnetzki, BM1
Hellewell, PG; Williams, TJ1
Benveniste, J; Denizot, Y; Dubertret, L; Michel, L; Thomas, Y1
Rampart, M; Williams, TJ1

Other Studies

11 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Dermatoses

ArticleYear
Characterization of platelet-activating factor-induced cutaneous edema and erythema in dogs.
    American journal of veterinary research, 2016, Volume: 77, Issue:9

    Topics: Animals; Azepines; Dogs; Edema; Erythema; Histamine; Male; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prednisolone; Receptors, G-Protein-Coupled; Skin; Skin Diseases; Triazoles

2016
Effects of Y-24180, a receptor antagonist to platelet-activating factor, on allergic cutaneous eosinophilia in mice.
    Life sciences, 1999, Volume: 64, Issue:11

    Topics: Animals; Azepines; Cytokines; Eosinophilia; Hypersensitivity; Male; Mice; Mice, Inbred BALB C; Platelet Activating Factor; Skin Diseases; Triazoles

1999
VCAM-1 contributes to rapid eosinophil accumulation induced by the chemoattractants PAF and LTB4: evidence for basal expression of functional VCAM-1 in rat skin.
    Immunology, 1999, Volume: 97, Issue:1

    Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Chemotaxis, Leukocyte; Dactinomycin; Edema; Eosinophils; Immunoenzyme Techniques; Integrin alpha4; Integrins; Leukotriene B4; Male; Platelet Activating Factor; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Skin; Skin Diseases; Vascular Cell Adhesion Molecule-1

1999
Suppression of the Arthus reaction by Y-24180, a potent and specific antagonist of platelet-activating factor.
    Agents and actions, 1992, Volume: 35, Issue:3-4

    Topics: Animals; Arthus Reaction; Azepines; Capillary Permeability; Disease Models, Animal; Female; Guinea Pigs; Male; Molecular Structure; Ovalbumin; Pancreatitis; Platelet Activating Factor; Rabbits; Rats; Rats, Inbred Strains; Skin; Skin Diseases; Triazoles

1992
Effect of SR 27417 on oedema formation induced in rabbit skin by platelet-activating factor or antigen.
    European journal of pharmacology, 1992, Jun-05, Volume: 216, Issue:2

    Topics: Allergens; Animals; Antigens; Edema; Injections, Intravenous; Male; Ovalbumin; Platelet Activating Factor; Rabbits; Skin Diseases; Thiazoles

1992
A model for the investigation of factors influencing haemorrhagic necrosis mediated by tumour necrosis factor in tissue sites primed with mycobacterial antigen preparations.
    Clinical and experimental immunology, 1992, Volume: 88, Issue:3

    Topics: Animals; Antigens, Bacterial; Complement System Proteins; Elapid Venoms; Female; Hemorrhage; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Misoprostol; Mycobacterium; Necrosis; Platelet Activating Factor; Skin Diseases; Tumor Necrosis Factor-alpha

1992
The induction of plasma leakage in skin by histamine, bradykinin, activated complement, platelet-activating factor and serotonin.
    Immunology and cell biology, 1991, Volume: 69 ( Pt 3)

    Topics: Animals; Autacoids; Bradykinin; Cell Membrane Permeability; Complement System Proteins; Histamine; Male; Microcirculation; Platelet Activating Factor; Serotonin; Serum Albumin; Sheep; Sheep Diseases; Skin; Skin Diseases; Vasculitis

1991
Comparative studies of human eosinophil migration towards platelet-activating factor and leukotriene B4.
    International archives of allergy and applied immunology, 1989, Volume: 88, Issue:1-2

    Topics: Cell Movement; Chemotaxis, Leukocyte; Eczema; Eosinophilia; Eosinophils; Humans; In Vitro Techniques; Leukotriene B4; Neutrophils; Platelet Activating Factor; Skin Diseases

1989
Antagonism of Paf-induced oedema formation in rabbit skin: a comparison of different antagonists.
    British journal of pharmacology, 1989, Volume: 97, Issue:1

    Topics: Animals; Edema; In Vitro Techniques; Injections, Intradermal; Injections, Intravenous; Male; Platelet Activating Factor; Rabbits; Skin Diseases

1989
Release of PAF-acether and precursors during allergic cutaneous reactions.
    Lancet (London, England), 1988, Aug-13, Volume: 2, Issue:8607

    Topics: Adult; Female; Humans; Hypersensitivity; Male; Platelet Activating Factor; Skin Diseases; Skin Tests

1988
Polymorphonuclear leukocyte-dependent plasma leakage in the rabbit skin is enhanced or inhibited by prostacyclin, depending on the route of administration.
    The American journal of pathology, 1986, Volume: 124, Issue:1

    Topics: Alprostadil; Animals; Bradykinin; Complement C5; Complement C5a, des-Arginine; Drug Synergism; Edema; Epoprostenol; Infusions, Parenteral; Injections, Intradermal; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Plasma Volume; Platelet Activating Factor; Rabbits; Skin Diseases

1986